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A hemoglobin-binding protein (HgbA) from Haemophilus ducreyi was identified and purified. The 100-kDa
HgbA was detected in all strains of H. ducreyi tested, and a somewhat larger hemoglobin-binding protein was
found in one strain of Haemophilus influenzae. HgbA was purified and the amino acid sequence of the N
terminus of HgbA revealed no significant homologies with known proteins. Two different antisera to HgbA from
H. ducreyi 35000 recognized HgbA proteins from all tested H. ducreyi strains; they did not recognize proteins
from the H. influenzae strain. Expression of HgbA was regulated by the level of heme but not by iron present
in the medium. Animal species of hemoglobin competed with iodinated human hemoglobin for binding to whole
cells of H. ducreyi and supported the growth of H. ducreyi. The lack of immunological cross-reactivity and the
differences in hemoglobin specificities between the H. ducreyi and the H. influenzae hemoglobin-binding
proteins suggest that they are unrelated.
The sexually transmitted disease chancroid is caused by Hae-
mophilus ducreyi, a fastidious, slowly growing gram-negative
rod (3, 19). Little is known regarding its genetics, immunology,
or growth and nutritional requirements. Reinfection is com-
mon and autoinoculation of infectious material results in chan-
cres, suggesting that there is no acquired immunity during
natural infection. Recent clinical evidence from Africa clearly
demonstrates that chancroid is a risk factor for the spread of
human immunodeficiency virus among heterosexuals (23). Al-
though this suggests that a vaccine against H. ducreyi could
contribute to reducing the transmission of human immunode-
ficiency virus, no vaccine candidates are available.
Iron limitation in vivo is a major obstacle which infecting
bacteria must overcome to proliferate and produce disease
(reviewed in reference 21). The poor water solubility of iron
coupled with the ability of host iron-binding proteins to scav-
enge iron limits the concentration of free iron, and this limi-
tation serves as a first line of defense (21). H. ducreyi must
obtain heme from its host, since it is unable to synthesize heme
(4). Hemoglobin can serve as a source of heme for H. ducreyi
growth (4) and is presumably obtained from the lysis of eryth-
rocytes by the hemolysin of H. ducreyi (22).
Certain pathogenic bacteria, including H. ducreyi (1, 14), do
not secrete siderophores but rather have evolved receptors and
transport systems to obtain iron directly from host iron-binding
proteins (21, 25). Examples of such systems are found in the
pathogenic Neisseria spp. and H. influenzae (6). H. influenzae
utilizes the iron from transferrin and lactoferrin as well as from
heme-hemopexin, heme-albumin, and haptoglobin-hemoglo-
bin (24). H. influenzae (11, 12, 15, 26) and other mucosal
pathogens (16) express several heme- or heme-hemopexin-
binding proteins. Interestingly, the transferrin receptor (20)
and the hemoglobin receptor (10) of H. influenzae are regu-
lated by heme but not by elemental iron levels in the medium.
Like H. influenzae, H. ducreyi also requires some form of heme
for aerobic growth, but little is known regarding its heme
acquisition systems. Lee studied the sources of iron utilized by
H. ducreyi 35000 as well as the effect of heme on outer mem-
brane protein composition. He reported that heme and hemo-
globin (singly or complexed to the serum carriers albumin and
haptoglobin, respectively) were capable of serving as iron
sources. Ferric chloride, human lactoferrin, and transferrin
failed to support growth. Outer membrane proteins of 40.5,
45.5, 50, and 65 kDa were induced under conditions of low
levels of heme (14).
The objectives of this study were to determine whether H.
ducreyi produces a receptor for hemoglobin and, if so, to iso-
late and characterize the receptor.
MATERIALS AND METHODS
Bacteria, growth conditions, and preparation of membranes. The H. ducreyi
type strain, 35000, was obtained from Stanley Spinola, Indiana University,
Bloomington, Ind. H. ducreyi CIP542, C110, C111, 26V, and 4V were obtained
from William Albritton, Ontario, Canada. Strains 2723, 2732, 2744, 2745, 2749,
2753, 2774, and 2780 were recently isolated from patients in Malawi and were
obtained from the Sexually Transmitted Infections Research Center, University
of North Carolina at Chapel Hill. H. influenzae DL42 and its isogenic heme-
hemopexin mutant (12) were obtained from Eric Hansen, University of Texas
Health Science Center, Dallas. Neisseria gonorrhoeae FA19 was previously de-
scribed (18). H. ducreyi strains were routinely passaged every 48 h on chocolate
agar. For growth of H. ducreyi 35000 under heme-limiting conditions on solid
medium, bacteria were heavily inoculated into gonococcal medium base (GC
Base; Difco, Detroit, Mich.) containing Isovitalex (Baltimore Biological Labo-
ratory, Cockeysville, Md.) and either 5 (heme depleted) or 50 (heme replete) mg
of heme per ml. Five micrograms of heme per milliliter in solid medium does not
support extended growth of H. ducreyi (3, 4, 7) (data not shown), unless the
medium is heavily inoculated from a heme-replete medium (chocolate). Liquid
cultures of H. ducreyi were grown in gonococcal medium broth (the same com-
ponents as GC Base without the agar) with Isovitalex, 5% heat-inactivated fetal
calf serum, and various amounts of heme as indicated. In experiments using
liquid medium without added heme (see Fig. 4), the growth observed was pre-
sumably due to heme carryover from the chocolate agar plates used to inoculate
the liquid medium.
Two different methods were used to test the ability of animal hemoglobins to
support the growth of H. ducreyi 35000. For the first method, GC base (GCB)
agar with Isovitalex (GCB-I agar) was prepared and inoculated with strain 35000,
such that confluency or near confluency was obtained. Sterile filter discs (diam-
eter, 6 mm) were then placed on the surface of the agar, and hemoglobin, globin
(500 mg), or heme (50 mg) was spotted onto separate discs. Growth around each
disc was monitored after 48 and 72 h in a 5% CO2 environment at 358C. Growth
around the disc was considered a positive result, and no growth was considered
a negative result. The positive control was the heme disc. For the second method,
GCB-I agar containing either 100 or 500 mg of hemoglobin per ml from different
animal sources was prepared. Plates were inoculated with 100 CFU and were
recorded as positive if individual colonies developed after 48 to 72 h. The positive
control was a GCB-I plate containing 50 mg of heme per ml, and the negative
control was a GCB-I plate lacking heme or hemoglobin.
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Outer membranes were prepared as follows. Whole H. ducreyi cells were
sonicated with a Fisher dismembranator model 300 fitted with a microtip probe
at a setting of 35% for 5 min on ice. Intact cells and cell debris were removed by
centrifugation at 12,0003 g for 10 min at 48C, and the supernatant was removed.
The supernatant was then subjected to centrifugation at 100,000 3 g for 1 h at
48C, which yielded a total membrane pellet. The total membrane pellet was
rinsed twice with water without disturbing the pellet and was solubilized with 1%
Sarkosyl at room temperature for 1 h with rocking. The suspension of total
membranes was subjected to centrifugation at 100,0003 g for 1 h at 48C, and the
Sarkosyl-soluble cytoplasmic membrane supernatant was removed. The Sarko-
syl-insoluble pellet was resuspended into 1% Sarkosyl and repelleted, and the
pellet was termed outer membranes.
Purification and N-terminal amino acid sequence determination of HgbA. For
purification of HgbA, a hemoglobin-binding protein, analytical purifications
were performed in microcentrifuge tubes, whereas preparative purifications uti-
lized a column format. Outer membranes or whole cells were solubilized by using
the detergent Zwittergent 3,14 (Calbiochem, La Jolla, Calif.) in 50 mM Tris–150
mM NaCl–5 mM EDTA, pH 7.5, with end-over-end tumbling at 378C for 1 h.
After centrifugation (at 100,000 3 g, 1 h, 48C), the soluble fraction was mixed
with solid-phase hemoglobin-agarose (Sigma) and gently rocked for 1 h at room
temperature or overnight at 48C. The agarose containing the ligand-receptor
complex was washed in the above-mentioned buffer to remove nonspecifically
bound protein. HgbA was eluted in Laemmli sample buffer for analytical sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western
blotting (immunoblotting). Alternatively, for immunizations, HgbA was eluted
with guanidine HCl, concentrated in a Centricon 30 (Millipore), and dialyzed
overnight against phosphate-buffered saline (PBS) at 48C. For N-terminal amino
acid analysis, purified HgbA or outer membranes were electrophoresed by SDS-
PAGE, electroblotted to polyvinylidene difluoride (Bio-Rad, Richmond, Calif.),
and located by Coomassie staining of the filter. The N-terminal amino acid
sequence was determined by Feng Wang of ImClone Systems, New York, N.Y.
The N-terminal amino acid sequence was determined by standard Edman deg-
radation on a model ABI 477A microsequencer (Applied Biosystems, Foster
City, Calif.).
Peptide synthesis and immunizations. Peptide synthesis was performed at the
Microchemical Core Facility in the Department of Microbiology and Immunol-
ogy at the University of North Carolina, Chapel Hill. Polyethylene glycol-poly-
styrene resin was used on a Symphony (Applied Biosystems) multiple-peptide
synthesizer. Each peptide was double coupled by standard Fmoc chemistry. The
peptide was purified by reverse-phase high-pressure liquid chromatography, the
sequence was confirmed by Edman degradation, and the molecular weight was
determined by fast atom bombardment-mass spectrometry. Two glycines (for
spacers) and a terminal cysteine were included at the carboxyl-terminal end for
coupling of the peptide to carrier protein or for coupling to thiopropyl agarose.
Keyhole limpet hemocyanin (KLH) was used as the carrier protein, and it was
coupled to the peptide utilizing m-maleimidobenzoyl-N-hydroxysuccinimide es-
ter (Pierce), according to the manufacturer’s instructions. Two New Zealand
White female rabbits were immunized three times, with either purified HgbA or
N-terminal peptide coupled to KLH in Ribi adjuvant as directed by the manu-
facturer (Ribi Immunochemicals, Missoula, Mont.). One hundred micrograms of
purified HgbA or 500 mg of N-terminal peptide coupled to KLH was used for
each immunization. Rabbits were bled prior to and 2 and 4 weeks after the last
immunization.
Analytical assays. SDS-PAGE, Western blotting dot blotting, and enzyme-
linked immunosorbent assays (ELISA) were performed as described by Harlow
and Lane (13) and modified as described below. The secondary reagent used for
the Western blotting was protein A-alkaline phosphatase (Sigma) at a 1:2,000
dilution. Affinity purifications of antipeptide antisera were performed as previ-
ously reported (9).
Hemoglobin labeling and dot blots. Human hemoglobin (Sigma) was labeled
with 125I by using Iodogen (Pierce) as described by the manufacturer. Approx-
imately 2 3 107 CFU of strain 35000 in 100 ml of PBS was immobilized onto
nitrocellulose by vacuum filtration. The bacteria were allowed to dry for 10 min
at 378C, and the filters were blocked with 5% skim milk in Tris-buffered saline
(50 mM Tris [pH 7.5], 100 mM NaCl) for 30 min at room temperature. Two
million counts per minute of 125I-hemoglobin diluted in 5 ml of 5% skim milk in
Tris-buffered saline was used per blot and incubated for 2 h at room temperature.
Washes were performed three times for 10 min in Tris-buffered saline. In he-
moglobin competition experiments, a 100 M excess of each competitor was
premixed with 125I-human hemoglobin prior to probing the blots. Imaging was
performed on a Molecular Dynamics phosphoimaging system after overnight
exposure.
RESULTS
Identification, purification, and N-terminal amino acid se-
quence of a hemoglobin-binding protein. H. ducreyi cannot
synthesize heme. In the host, heme can be supplied by either
heme or hemoglobin (3, 4). Thus, H. ducreyi must have heme
and/or hemoglobin receptors. To test this hypothesis, solubi-
lized outer membranes of strain 35000 were subjected to af-
finity purification on immobilized human hemoglobin as de-
scribed in Materials and Methods. This reproducibly yielded a
single protein with a molecular mass of about 100 kDa (Fig. 1).
The growth conditions for the experiment whose results are
presented in Fig. 1 were GCB-I broth containing 5 mg of heme
per ml. Amino acid sequence analysis of purified HgbA (Fig. 1,
lane 3) and the comigrating outer membrane protein (Fig. 1,
lane 1) yielded the identical N-terminal sequence ES-
NMQTEKLETIVV, suggesting that they were the same pro-
tein. A BLAST search (5) of the GenBank database found no
significant homologies.
Peptide synthesis and immune response to HgbA. Synthesis
of a 14-mer, corresponding to the 14 N-terminal amino acids of
HgbA with two additional glycine spacers and a terminal cys-
teine, by standard methods was unsuccessful on two occasions,
presumably because of solubility problems (17a). To circum-
vent this problem, a shorter peptide lacking the four C-termi-
nal hydrophobic amino acids (TIVV) was successfully synthe-
sized and was the only peptide used in this study. The sequence
of this peptide is ESNMQTEKLEGGC. This N-terminal
HgbA peptide was coupled to KLH for immunizations and was
also coupled to an affinity support for antibody purification.
Two rabbits were immunized with either purified HgbA (Fig. 1,
lane 3) or synthetic N-terminal HgbA peptide conjugated to
KLH. Serum from one rabbit injected with each immunogen
reacted in an ELISA format with purified HgbA as the coating
antigen (data not shown). The postimmune antipeptide serum
was affinity purified on a thiopropyl agarose column to which
the synthetic peptide had been coupled in order to eliminate
reactivity to antigens other than HgbA (data not shown).
The specificity of the affinity-purified antipeptide serum and
the anti-HgbA serum was assayed by Western blotting with
whole-cell lysates from a variety of H. ducreyi strains as well as
control H. influenzae DL42 and N. gonorrhoeae FA19 (Fig. 2).
These H. ducreyi strains included two type strains and several
clinical isolates from diverse geographical areas. To critically
examine the sera for specificity, H. ducreyi strains were grown
on chocolate agar, a heme-replete medium, which repressed
expression of HgbA (see below). This was meant to provide a
rigorous test of specificity, since HgbA expression would be
repressed and constitutively expressed proteins would be ex-
pressed. The affinity-purified antipeptide serum recognized
HgbA strongly and recognized a few other proteins weakly
(Fig. 2A), whereas the anti-HgbA serum recognized HgbA and
several other unelicited antigens (Fig. 2B). Preimmune sera of
all four rabbits did not recognize any antigens by Western
blotting at a dilution of 1:2,000 (not shown). The molecular
FIG. 1. Identification of a hemoglobin-binding protein in H. ducreyi. SDS–
7.5% PAGE gels stained with Coomassie blue. Lane 1, H. ducreyi outer mem-
branes; lane 2, H. ducreyi Zwittergent 3,14-soluble outer membranes; lane 3,
purified HgbA.
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mass of the major immunoreactive protein from each of the
tested strains was approximately 100 kDa. No immunoreactive
proteins in this size range were identified from whole-cell ly-
sates of H. influenzae DL42 or N. gonorrhoeae FA19 (Fig. 2,
lanes 10 through 12).
Functional and immunological conservation of HgbA. The
data from Western blotting demonstrated that there was a
conserved protein present in several strains of H. ducreyi which
was immunologically related to the HgbA of H. ducreyi 35000.
In order to address whether these immunoreactive proteins
were actually hemoglobin-binding proteins, affinity purification
was performed with the same strains as those used for Fig. 2.
The Coomassie-stained gel shown in Fig. 3A demonstrated
that all tested H. ducreyi strains contained a protein with a
similar molecular weight which eluted from immobilized hu-
man hemoglobin. H. influenzae also had a hemoglobin-binding
protein that was larger in apparent molecular weight. In order
to confirm that the immunologically related proteins shown in
the whole-cell lysate Western blots (Fig. 2) were the same as
the hemoglobin-binding proteins (Fig. 3A), purified HgbA
proteins from the same strains were probed in Western blots
with affinity-purified antipeptide serum (Fig. 3B) or antiserum
to purified HgbA (Fig. 3C). The purified hemoglobin-binding
proteins of all tested H. ducreyi strains, including five addi-
tional strains not shown here, strongly cross-reacted with both
antisera. A protein with a similar molecular mass (100 kDa)
which bound heme-hemopexin in H. influenzae was previously
described (12). In order to determine whether HgbA was the
heme-hemopexin protein, hemoglobin affinity was applied to
H. influenzae DL42 and its isogenic heme-hemopexin receptor
mutant DL42 cat D107 (Fig. 3A, lanes 10 and 11). Since both
the wild-type and mutant H. influenzae strains contained a
hemoglobin-binding protein, the heme-hemopexin protein is
not the same protein. The hemoglobin-binding protein fromH.
influenzae had a larger molecular mass (approximately 115
kDa) than HgbA from H. ducreyi strains (Fig. 3A) and the
heme-hemopexin receptor of H. influenzae (11). The hemoglo-
bin-binding protein from H. influenzae was not recognized by
either antipeptide or anti-HgbA antibody from H. ducreyi (Fig.
3B and C, lanes 10 and 11). Gonococcal strain FA19 did not
contain a protein that bound hemoglobin in this format or that
was recognized by either anti-HgbA serum.
Heme regulation and surface exposure of HgbA. Other bac-
teria which express receptors for host iron-containing com-
pounds do so under conditions of iron or heme limitation; thus,
it was possible that HgbA was also iron or heme regulated (17).
Attempts to iron starve H. ducreyi in order to increase expres-
sion of HgbA or other proteins, utilizing deferoxamine mesy-
late (Ciba-Geigy, Summit, N.J.) or 2,2 dipyridyl (Sigma) (data
not shown), were unsuccessful. The former compound had no
effect on the growth of strain 35000, whereas the latter did slow
the growth somewhat. It is possible that the intracellular iron
pools are determined primarily through the uptake of heme
iron rather than other iron sources. Therefore, H. ducreyi
35000 was grown in various concentrations of heme, and cul-
tures were examined for surface expression of HgbA. Surface-
iodinated whole cells were subjected either to SDS-PAGE and
autoradiography (Fig. 4A) or HgbA affinity purification fol-
lowed by SDS-PAGE and autoradiography (Fig. 4B). A heme-
regulated surface-exposed protein with a molecular mass of
about 100 kDa was present in whole-cell lysates (Fig. 4A). This
protein was HgbA, since it could be affinity purified on immo-
bilized hemoglobin from the same iodinated H. ducreyi cells
(Fig. 4B). Further proof of heme regulation and the outer
membrane localization of HgbA was obtained by fractionation
of H. ducreyi grown with various concentrations of heme. SDS-
FIG. 2. Western blot analysis of the immune response to HgbA N-terminal
peptide and HgbA protein. Whole-cell lysates of H. ducreyi, H. influenzae, and N.
gonorrhoeae were probed with either postimmune affinity-purified antipeptide
serum (1 mg/ml) (A) or postimmune anti-HgbA (holoprotein) serum (1:2,000)
(B). Protein from approximately 4 3 107 CFU of each strain was applied per
lane. Lanes 1 through 9: H. ducreyi 35000, CIP542, 4V, 26V, C110, C111, 2745,
2753, and 2774, respectively. Lane 10, H. influenzae DL42; lane 11, H. influenzae
DL42 cat D107 (heme-hemopexin receptor mutant); lane 12, N. gonorrhoeae
FA19; lane 13, purified HgbA from H. ducreyi 35000.
FIG. 3. Functional and immunological conservation of HgbA. H. ducreyi, H.
influenzae, and N. gonorrhoeae were subjected to analytical format hemoglobin
affinity purification, as described in the text. (A) Coomassie-stained SDS–7.5%
PAGE gel of purified HgbA. (B) Western blot of purified HgbA proteins as in
panel A, with affinity-purified antipeptide serum. (C) Western blot of HgbA
proteins as in panel B, with polyclonal rabbit postimmune anti-HgbA serum to
the HgbA from strain 35000. Lanes 1 through 9 show proteins from various H.
ducreyi strains. Lanes: 1, 35000; 2, CIP542; 3, 4V; 4, 26V; 5, C110; 6, C111; 7,
2745; 8, 2753; 9, 2774. Lane 10, H. influenzae DL42; lane 11, H. influenzae DL42
cat D107 (heme-hemopexin receptor mutant); lane 12, N. gonorrhoeae FA19.
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PAGE gels of outer membranes were either Coomassie
stained (Fig. 4C) or subjected to Western blotting (Fig. 4D).
Thus, heme concentrations in the medium regulate HgbA sur-
face expression and hemoglobin binding. HgbA was surface
exposed by using several techniques: surface iodination, Sar-
kosyl-insoluble outer membrane fractionation, and (not
shown) surface biotinylation.
Specificity of hemoglobin binding and the ability of human
and animal hemoglobins to support the growth of H. ducreyi.
In several pathogenic bacterial systems, the receptor for host
iron-containing compounds is species specific. In order to test
whether this is true for HgbA, a competitive dot blot was
performed (Fig. 5). Various animal hemoglobins were mixed
with 125I-human hemoglobin (100:1 [molar], cold competitor
to iodinated probe) and used to probe H. ducreyi grown under
heme-depleted conditions. All animal hemoglobins competed
well for binding. In contrast, neither heme nor globin signifi-
cantly competed. The binding of iodinated hemoglobin without
competitor was heme regulated (compare the far left and right
lanes), confirming the results seen in Fig. 4.
The ability of animal hemoglobins and heme to support the
growth of strain 35000 in a bioassay disc format and also on
plates containing these compounds incorporated into GCB-I
agar was tested. All tested hemoglobins and heme supported
growth adjacent to the discs, but globin did not (Fig. 5B).
When incorporated in GCB-I medium, all animal hemoglobins
at a concentration of 100 mg/ml also supported the growth of
strain 35000.
Data in Fig. 3 demonstrated that all tested H. ducreyi strains
contained HgbA. However, Albritton et al. (4) reported that
two of the strains (C110 and 4V) could not grow in a complex
‘‘clear medium base’’ containing 0.1% hemoglobin as the sole
source of heme. To test whether human hemoglobin could
support the growth of H. ducreyi, all the H. ducreyi strains used
for Fig. 3 were inoculated onto GCB-I agar containing various
amounts of human hemoglobin. All strains grew on GCB-I
agar plates containing either 100 or 500 mg of human hemo-
globin per ml. The difference in growth seen between the
previous study (4) and the present one is probably due to the
differences in the medium base rather than to an inability to
use hemoglobin, since GCB-I is a more enriched medium than
the ‘‘clear medium base’’ (2). It should be noted that strains
C110 and 4V grew more slowly relative to the other strains in
all media used in this study.
DISCUSSION
In the present study, an approximately 100-kDa hemoglo-
bin-binding protein from H. ducreyi and a slightly larger pro-
tein from H. influenzae were identified and purified. Several
other mucosal pathogens contain receptors for binding host
iron-containing proteins and some have a similar molecular
mass. For example, pathogenic Neisseria spp. contain 100-kDa
transferrin and lactoferrin receptors which are homologous to
the TonB-dependent receptors (6). Several Escherichia coli
outer membrane siderophore receptors are TonB dependent
and transport the iron-containing ligand (siderophore) across
the outer membrane (17). It remains to be seen whether HgbA
is a member of this family and whether heme is stripped from
the hemoglobin prior to internalization.
HgbA is apparently conserved inH. ducreyi. In a survey of 14
strains of geographically diverse isolates of H. ducreyi, similarly
sized HgbA proteins were present in all strains. Additionally,
significant cross-reactivity was demonstrated with two different
antisera to H. ducreyi 35000. One of these antisera was to an
N-terminal peptide of only 10 amino acids. Investigations using
surface iodination, whole-cell dot blot binding of hemoglobin,
Sarkosyl-insoluble outer membrane fractionation, and surface
biotinylation demonstrated that HgbA was located in the outer
membrane. Since HgbA is a surface-exposed, conserved anti-
gen, it may be possible to use HgbA as a diagnostic tool or
vaccine component, although further studies in this area are
needed.
Many bacterial receptors for iron compounds are regulated
by iron or heme. Lee demonstrated that several outer mem-
brane proteins of H. ducreyi were heme regulated (14). How-
ever, a 100-kDa protein was strongly heme regulated (Fig. 2 of
reference 14 [compare lanes g and h]) but was not mentioned.
It is likely that this protein is HgbA. Recently, the transferrin
receptor (20) and a hemoglobin receptor (10) of H. influenzae
FIG. 4. Regulation of HgbA by heme and surface exposure. H. ducreyi 35000
was grown overnight in GCB broth with various concentrations of heme and
subjected to the following analyses. (A) Autoradiograph of whole-cell lysates of
iodinated H. ducreyi. (B) Autoradiograph of purified HgbA from iodinated H.
ducreyi. (C) Coomassie blue-stained SDS-PAGE gel of Sarkosyl-insoluble outer
membranes. (D) Western blot of outer membranes, using affinity-purified anti-
peptide serum. Lanes 1, no added heme; lanes 2, 1 mg of heme per ml; lanes 3,
5 mg of heme per ml; lanes 4, 50 mg of heme per ml. Lane 5 in panels C and D
contains 0.25 mg of purified HgbA.
FIG. 5. Species specificity of HgbA for animal hemoglobins. (A) Hemoglobin
competition assay. Dot blot of immobilized whole cells of H. ducreyi 35000 grown
under heme stress and probed with 125I-human hemoglobin alone or with com-
petitors as indicated. The four dots in each column represent quadruplicate
determinations. None*, H. ducreyi 35000 grown under heme excess and probed
with 125I-human hemoglobin in the absence of competitor. (B) Ability of animal
hemoglobins, globin, and heme to support the growth of H. ducreyi 35000. A plus
sign indicates growth, and a minus sign indicates no growth. See the text for
details.
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were shown to be regulated by heme rather than by elemental
iron. In the present study I show that HgbA is heme regulated
but not iron regulated. It is possible that heme concentrations
in the medium determine partly or wholly the intracellular iron
concentrations.
The H. influenzae hemoglobin receptor is specific for human
hemoglobin (10). In contrast, HgbA showed no such specificity
for human hemoglobin; all tested species of hemoglobin suc-
cessfully competed for binding. These same hemoglobins also
supported the growth of the H. ducreyi type strain, 35000. This
suggests that there is a conserved motif in the domain bound in
animal hemoglobins that is recognized by HgbA.
The unidentified H. influenzae hemoglobin-binding activity
described by Frangipane et al. (10) may be mediated by the H.
influenzae hemoglobin-binding protein described here. The he-
moglobin-binding protein of H. influenzae was immunologi-
cally distinct from the hemoglobin-binding protein of H. du-
creyi. These immunologic data, coupled with the different
hemoglobin-binding specificities observed for the H. influenzae
and H. ducreyi proteins, suggest that hemoglobin-binding pro-
teins from the two species are unrelated.
In summary, HgbA is a conserved, surface-exposed, hemo-
globin-binding protein. Recently, I have cloned the gene en-
coding HgbA in E. coli, and the recombinant E. coli binds
human hemoglobin (8), implicating HgbA as a receptor.
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